Archive by Tag: patients

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products

July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications. Thought Leader Select, headquartered in Chapel[...]

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives

(CHAPEL HILL, NC) Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas. Thought Leader Select, headquartered in Chapel Hill,[...]

Corporate Responsibility at Thought Leader Select

By Brian Castle and Kristen Smithwick At Thought Leader Select, we have the privilege of working with a group of people who are always mindful of our company’s place in the big world of healthcare. We view our mission as[...]

Thought Leader Select Announces New Assessments of Key Opinion Leaders, Centers of Excellence in Women’s Health, Oncology

Company News Thought Leader Select is pleased to announce a pair of projects in support of a top 10 global biopharmaceutical company as it seeks to develop a portfolio of medicines in women’s health. For the assessments, Thought Leader Select[...]

Clinical Trials—The New Way Forward

Industry Insights from Paul Meade, M. Sc, MPH A recent article in the Wall Street Journal announced that Pfizer is conducting a clinical trial in which patients are able to use their computers and smartphones to enter information about the[...]

Clinical Trial Ethics

Industry Insights from Paul Meade, M. Sc, MPH According to an article published in the Archives of Internal Medicine, Dr Joseph Ross claimed a study conducted by Parke-Davis, before it was acquired by Pfizer, using gabapentin (Neurontin), as the drug[...]

Fast Facts from Thought Leader Select—Trends in Diabetes Research among U.S. Primary Care Physicians

The International Diabetes Federation Atlas (http://www.diabetesatlas.org) reports that 285 million people aged 20-79 years globally have diabetes, a disease impacting most countries. According to the Centers for Disease Control (CDC) 2007 National Diabetes Fact Sheet, diabetes affects 23.6 million people[...]

The Future Integration of Long-Term Care by the Screenagers

Industry Insights from Paul Meade, M. Sc, MPH One word that optimally summarizes long-term care in the United States is fragmentation. Like a microcosm of the overall fragmented healthcare system in the U.S., long-term care suffers from similarly fragmented clinical[...]

Power to the Patients: Takeaways from the "New Health Report"

Industry Insights from Paul Meade, M. Sc, MPH A recent report suggested that patients can have a significant influence on the success or failure of new drugs. The “New Health Report,” conducted by Richard Day Research and published by Quintiles,[...]

Social Media Offers Pharma, Physicians Opportunities for Better Interaction with Consumers

In a recent Marketing: Health blog post at MediaPost, Kathy Thorbahn of Razorfish Health, a marketing/advertising/public relations firm focused on health care industries, makes a strong case for the pharmaceutical industry to fully embrace social media in its efforts to[...]